These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34595951)

  • 1. Formulary tiers, medication cost sharing, and transparency in bronze and silver qualified health plans in 2014 vs 2018.
    Hung A; Sauvageau G
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1332-1340. PubMed ID: 34595951
    [No Abstract]   [Full Text] [Related]  

  • 2. An early examination of access to select orphan drugs treating rare diseases in health insurance exchange plans.
    Robinson SW; Brantley K; Liow C; Teagarden JR
    J Manag Care Spec Pharm; 2014 Oct; 20(10):997-1004. PubMed ID: 25278322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do drug formulary policies reflect evidence of value?
    Neumann PJ; Lin PJ; Greenberg D; Berger M; Teutsch S; Mansley E; Weinstein MC; Rosen AB
    Am J Manag Care; 2006 Jan; 12(1):30-6. PubMed ID: 16402886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Consumer Cost-Sharing for Health Plans Sold in the ACA's Insurance Marketplaces, 2015 to 2016.
    Gabel J; Green M; Call A; Whitmore H; Stromberg S; Oran R
    Issue Brief (Commonw Fund); 2016 May; 11():1-14. PubMed ID: 27214926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the Value of Subsidies of Health Plans and Cost-Sharing for Prescription Drugs in the Health Insurance Marketplace.
    Ngorsuraches S; Mort JR
    Am Health Drug Benefits; 2016 Oct; 9(7):368-377. PubMed ID: 27994712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a One-Size-Fits-All Cost-Sharing Approach Incentivize Appropriate Medication Use? A Roundtable on the Fairness and Ethics Associated with Variable Cost Sharing.
    Graff JS; Shih C; Barker T; Dieguez G; Larson C; Sherman H; Dubois RW
    J Manag Care Spec Pharm; 2017 Jun; 23(6):621-627. PubMed ID: 28530519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ACA’s Cost-Sharing Reduction Plans: A Key to Affordable Health Coverage for Millions of U.S. Workers.
    Gabel J; Whitmore H; Green M; Call A; Stromberg S; Oran R
    Issue Brief (Commonw Fund); 2016 Oct; 35():1-12. PubMed ID: 27827407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a Budget Impact Model Framework to Evaluate Antidiabetic Formulary Changes and Utilization Management Tools.
    Hung A; Mullins CD; Slejko JF; Haines ST; Shaya F; Lugo A
    J Manag Care Spec Pharm; 2019 Mar; 25(3):342-349. PubMed ID: 30816818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. California's New Gold Rush: Marketplace Enrollees Switch To Gold-Tier Plans In Response To Insurance Premium Changes.
    Rasmussen PW; Rice T; Kominski GF
    Health Aff (Millwood); 2019 Nov; 38(11):1902-1910. PubMed ID: 31682486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumer Cost-Sharing in Marketplace vs. Employer Health Insurance Plans, 2015.
    Gabel J; Whitmore H; Green M; Stromberg S; Oran R
    Issue Brief (Commonw Fund); 2015 Dec; 38():1-11. PubMed ID: 26761957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Affordable Care Act and the Burden of High Cost Sharing and Utilization Management Restrictions on Access to HIV Medications for People Living with HIV/AIDS.
    Zamani-Hank Y
    Popul Health Manag; 2016 Aug; 19(4):272-8. PubMed ID: 26565514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How does drug coverage vary by insurance type? Analysis of drug formularies in the United States.
    Régnier SA
    Am J Manag Care; 2014 Apr; 20(4):322-31. PubMed ID: 24884863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.
    Buttorff C; Andersen MS; Riggs KR; Alexander GC
    Health Aff (Millwood); 2015 Mar; 34(3):467-76. PubMed ID: 25732498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marketplace Plans Provide Risk Protection, But Actuarial Values Overstate Realized Coverage For Most Enrollees.
    Polyakova M; Hua LM; Bundorf MK
    Health Aff (Millwood); 2017 Dec; 36(12):2078-2084. PubMed ID: 29200356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When All That Glitters Is Gold: Dominated Plan Choice on Covered California for the 2018 Plan Year.
    Rasmussen PW; Anderson D
    Milbank Q; 2021 Dec; 99(4):1059-1087. PubMed ID: 34228827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing Medicare prescription drug plans in four states: balancing cost and access.
    Heaton E; Carino T; Dix H
    Issue Brief (Commonw Fund); 2006 Aug; 22():1-14. PubMed ID: 16933399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in Prescription Drug Coverage for Triptans: Analysis of Insurance Formularies.
    Minen MT; Lindberg K; Langford A; Loder E
    Headache; 2017 Sep; 57(8):1243-1251. PubMed ID: 28691382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Affordability Of Individual-Market Health Insurance In California Under The American Rescue Plan Act, 2021.
    Fung V; Price M; Wolf E; Newhouse JP; Hsu J
    Health Aff (Millwood); 2023 Jul; 42(7):1011-1020. PubMed ID: 37406234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plan Selection, Enrollee Risk, and Health Spending on the Patient Protection and Affordable Care Act Individual Marketplaces, 2019.
    Treasure G; Anderson DM; Hatcher L; Makhoul AE; Johnson D; Stefan J; Griffith KN
    JAMA Netw Open; 2023 Mar; 6(3):e234529. PubMed ID: 36995715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.